NORD Holding acquires pharmaceutical company NEC MED
NEC MED PHARMA is a specialist pharmaceutical and medical product trader in Germany. The company possesses a wide range of suppliers across all trade levels and distributes for a large number of established manufacturers. In 2016 NEC MED is achieving turnover of € 90 million and has about 50 employees. An average annual growth rate of 10 % has allowed the company to expand continually over recent years.
The participation of NORD Holding is intended to facilitate further expansion of the leading market position. "In line with the wish of my fellow shareholders to dispose of their shares, I have identified in NORD Holding an experienced partner, who promises to provide the best support for continuation of our growth", is the comment from long-established Manager Sven Rübner, who in future will remain managing shareholder in company leadership.
Completion of the transaction remains subject to approval from antitrust authorities.
It is a great pleasure for us to make this the third acquisition we have signed this year. We recognise significant potential in NEC MED both in the German market and in expanding our international position.
Manager of NORD Holding.
About NORD Holding
With its 50-year history and over € 2.0 billion assets under management, NORD Holding is one of the leading private equity asset managers in Germany with a focus on direct and fund investments.
The fund investments division targets the small- and mid-cap segment of the European private equity market through primaries, secondaries and co-investments.
NORD Holding has a strong focus on emerging buyout managers, hands-on investment strategies and regularly acts as an anchor investor. The division manages € 1.3 billion and ranks among the top decile fund investment groups in Europe.
The direct investments division of NORD Holding focuses on structuring and financing company succession models, acquiring parts of larger groups/subsidiaries as well as on expansion financing of medium-sized companies. In contrast to most other financial investors, who only manage closed-end funds, NORD Holding acts as a so-called "evergreen fund", thereby investing from its own balance sheet with no maturity restrictions. Currently, the fund has interests in more than 15 companies in the DACH region.